← Alle mensen

SG

Shirish Gadgeel

11 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025-04
NSCLC met driveralteraties: ASCO Living Guideline 2024.1
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2024
NSCLC zonder driveralteraties: ASCO Living Guideline 2024.1
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2024
Pembrolizumab plus pemetrexed-platina bij NSCLC: KEYNOTE-189 vijfjaars
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2023
Uitkomsten naar ALK-status bepaald door IHC of FISH bij ALK-positief NSCLC
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2021-02
Atezolizumab versus docetaxel bij NSCLC: IMpower210 definitief
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2021-01
Geactualiseerde KEYNOTE-189: pembrolizumab plus pemetrexed-platina bij NSCLC
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 mei 2020
PROs van pembrolizumab plus pemetrexed-platina bij NSCLC: KEYNOTE-189 analyse
The Lancet. Oncology · 2020-03
Cediranib plus cisplatine-pemetrexed bij onbehandeld mesothelioom: fase II
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 oktober 2019
Pembrolizumab plus chemotherapie bij gemetastaseerd NSCLC: KEYNOTE-189 fase III
The New England journal of medicine · 31 mei 2018
Alectinib versus crizotinib bij onbehandeld ALK-positief NSCLC: ALEX fase III-studie
The New England journal of medicine · 31 augustus 2017